OncoTherapy Science4564 
$0.262.78%24h
2.78%24h
Global rank24510
Market cap$50.16M
Change 7d-5.13%
YTD Performance60.87%
SP500 benchmarkOutperform
P/E-0.04
P/S6.28
Revenue$7.99M
Earnings-$7.87M
Dividend yield-
Main Sector
Healthcare
OncoTherapy Science (4564) Net Assets
4564 Net Assets in 2023: $855.17M
As of 19 Sept 2024, OncoTherapy Science net assets is $855.17M, an decrease of -56.81% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the OncoTherapy Science overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
OncoTherapy Science Net Assets History from 2019 to 2024
-
Value:-
4564 Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $855.17M | -56.81% |
| 2022 | $1.98B | -35.64% |
| 2021 | $3.08B | -34.93% |
| 2020 | $4.73B | -127.84% |
| 2019 | $-16.99B | - |
View the Top Net Assets Companies
